{"id":"https://openalex.org/W100598291","doi":"https://doi.org/10.1001/jama.298.2.194","title":"Efficacy and Safety of Incretin Therapy in Type 2 Diabetes","display_name":"Efficacy and Safety of Incretin Therapy in Type 2 Diabetes","publication_year":2007,"publication_date":"2007-07-10","ids":{"openalex":"https://openalex.org/W100598291","doi":"https://doi.org/10.1001/jama.298.2.194","mag":"100598291","pmid":"https://pubmed.ncbi.nlm.nih.gov/17622601"},"language":"en","primary_location":{"id":"doi:10.1001/jama.298.2.194","doi":"https://doi.org/10.1001/jama.298.2.194","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jama.298.2.194","pdf_url":null,"source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050742507","display_name":"Renee E. Amori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Renee E. Amori","raw_affiliation_strings":["Division of Endocrinology, Diabetes and Metabolism, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes and Metabolism, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA","institution_ids":["https://openalex.org/I1290900354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063528075","display_name":"Joseph T. F. Lau","orcid":"https://orcid.org/0000-0003-2344-7107","observed_orcids":["https://orcid.org/0000-0003-2344-7107"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph Lau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5088186669","display_name":"Anastassios G. Pittas","orcid":"https://orcid.org/0000-0002-0124-7174","observed_orcids":["https://orcid.org/0000-0002-0124-7174"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anastassios G. Pittas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":71.2754,"has_fulltext":false,"cited_by_count":1067,"citation_normalized_percentile":{"value":0.99967597,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"298","issue":"2","first_page":"194","last_page":"194"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9670000076293945},{"id":"https://openalex.org/keywords/incretin-based-therapy","display_name":"incretin-based therapy","score":0.9670000076293945},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8999999761581421},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9049999713897705},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.847000002861023},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9269999861717224},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.9079999923706055},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.8560000061988831},{"id":"https://openalex.org/keywords/infection-risk","display_name":"infection risk","score":0.8399999737739563},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6980000138282776},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.6650000214576721},{"id":"https://openalex.org/keywords/randomized-controlled-trials-meta-analysis","display_name":"randomized controlled trials meta-analysis","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.7852381467819214},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.758865237236023},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.663970947265625},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.5498507022857666},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4485432803630829},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4145117998123169},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38197261095046997},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2076837122440338}],"mesh":[{"descriptor_ui":"D000068900","descriptor_name":"Sitagliptin Phosphate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077597","descriptor_name":"Vildagliptin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018819","descriptor_name":"Dipeptidyl Peptidase 4","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D058892","descriptor_name":"Adenosine Deaminase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1001/jama.298.2.194","doi":"https://doi.org/10.1001/jama.298.2.194","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jama.298.2.194","pdf_url":null,"source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"journal-article"},{"id":"pmid:17622601","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17622601","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[{"id":"https://openalex.org/G3717891598","display_name":"Glycemic Index and Metabolic Syndrome","funder_award_id":"K23DK061506","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"}],"funders":[{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W1585447752","https://openalex.org/W1852436006","https://openalex.org/W1905803407","https://openalex.org/W1970406523","https://openalex.org/W1973383046","https://openalex.org/W1975588287","https://openalex.org/W1977119153","https://openalex.org/W1977619586","https://openalex.org/W1984588810","https://openalex.org/W1984740259","https://openalex.org/W1986085856","https://openalex.org/W1989976483","https://openalex.org/W1991565451","https://openalex.org/W2000442546","https://openalex.org/W2005038357","https://openalex.org/W2018192866","https://openalex.org/W2020638064","https://openalex.org/W2022101780","https://openalex.org/W2023462541","https://openalex.org/W2027249582","https://openalex.org/W2028272916","https://openalex.org/W2047353065","https://openalex.org/W2049323977","https://openalex.org/W2050826565","https://openalex.org/W2051462052","https://openalex.org/W2070214202","https://openalex.org/W2085862152","https://openalex.org/W2089304685","https://openalex.org/W2105875335","https://openalex.org/W2107328434","https://openalex.org/W2126930838","https://openalex.org/W2129377335","https://openalex.org/W2136254957","https://openalex.org/W2145335273","https://openalex.org/W2147817624","https://openalex.org/W2159205789","https://openalex.org/W2161893186","https://openalex.org/W2162934281","https://openalex.org/W2164416879","https://openalex.org/W2165698647","https://openalex.org/W2167621077","https://openalex.org/W2171512247"],"related_works":["https://openalex.org/W2045923887","https://openalex.org/W2064365715","https://openalex.org/W2058468402","https://openalex.org/W3172779288","https://openalex.org/W91242618","https://openalex.org/W2075070224","https://openalex.org/W2514777534","https://openalex.org/W2980615863","https://openalex.org/W1955912841","https://openalex.org/W2402222559"],"abstract_inverted_index":{"CONTEXT:":[0],"Pharmacotherapies":[1],"that":[2],"augment":[3],"the":[4,15,28,62,194,372,389],"incretin":[5,79,132],"pathway":[6],"have":[7],"recently":[8],"become":[9],"available,":[10],"but":[11,319],"their":[12],"role":[13,390],"in":[14,35,47,129,145,240,378,382],"management":[16],"of":[17,32,66,106,291,391],"type":[18,38,149,353,399],"2":[19,39,150,354,400],"diabetes":[20,40,138],"is":[21],"not":[22,334],"well":[23],"defined.":[24],"OBJECTIVE:":[25],"To":[26],"assess":[27],"efficacy":[29,174,330,358],"and":[30,61,103,109,140,161,175,191,218,228,245,250,276,301,310,331,359,375,381],"safety":[31,176,332],"incretin-based":[33],"therapy":[34,133,339],"adults":[36,147,351],"with":[37,134,148,202,352,356],"based":[41],"on":[42],"randomized":[43,74],"controlled":[44,75,118],"trials":[45,76,119,158,321],"published":[46],"peer-reviewed":[48],"journals":[49],"or":[50,86,136,325],"as":[51],"abstracts.":[52],"DATA":[53,152],"SOURCES:":[54],"We":[55,93],"searched":[56,95],"MEDLINE":[57],"(1966-May":[58],"20,":[59],"2007)":[60,71],"Cochrane":[63],"Central":[64],"Register":[65],"Controlled":[67],"Trials":[68],"(second":[69],"quarter,":[70],"for":[72,159,172,188,215,225,274,281,299,306,349,367,398],"English-language":[73],"involving":[77],"an":[78,288,341],"mimetic":[80],"(glucagonlike":[81],"peptide":[82,236,260],"1":[83,237,261],"[GLP-1]":[84],"analogue)":[85],"enhancer":[87],"(dipeptidyl":[88],"peptidase":[89,284],"4":[90,285],"[DPP4]":[91],"inhibitor).":[92],"also":[94],"prescribing":[96],"information,":[97],"relevant":[98,182],"Web":[99],"sites,":[100],"reference":[101],"lists":[102],"citation":[104],"sections":[105],"recovered":[107],"articles,":[108],"abstracts":[110],"presented":[111],"at":[112,125],"recent":[113],"conferences.":[114],"STUDY":[115],"SELECTION:":[116],"Randomized":[117],"were":[120,124,165,170,186,229,256],"selected":[121],"if":[122],"they":[123],"least":[126],"12":[127],"weeks":[128],"duration,":[130],"compared":[131,201],"placebo":[135,203,249],"other":[137,232],"medication,":[139],"reported":[141],"hemoglobin":[142,199],"A(1c)":[143,200],"data":[144],"nonpregnant":[146,350],"diabetes.":[151,401],"EXTRACTION:":[153],"Two":[154],"reviewers":[155],"independently":[156],"assessed":[157],"inclusion":[160,195],"extracted":[162],"data.":[163],"Differences":[164],"resolved":[166],"by":[167],"consensus.":[168],"Meta-analyses":[169],"conducted":[171],"several":[173],"outcomes.":[177],"RESULTS:":[178],"Of":[179],"355":[180],"potentially":[181],"articles":[183],"identified,":[184],"51":[185],"retrieved":[187],"detailed":[189],"evaluation":[190,377],"29":[192],"met":[193],"criteria.":[196],"Incretins":[197],"lowered":[198],"(weighted":[204],"mean":[205],"difference,":[206],"-0.97%":[207],"[95%":[208,220,271,278,296,303,315],"confidence":[209],"interval":[210],"{CI},":[211],"-1.13%":[212],"to":[213,223,231,344,387],"-0.81%]":[214],"GLP-1":[216],"analogues":[217,238,262],"-0.74%":[219],"CI,":[221,272,279,297,304,316],"-0.85%":[222],"-0.62%]":[224],"DPP4":[226,254,373],"inhibitors)":[227],"noninferior":[230],"hypoglycemic":[233,347],"agents.":[234],"Glucagonlike":[235,259],"resulted":[239],"weight":[241,257],"loss":[242],"(1.4":[243],"kg":[244,247],"4.8":[246],"vs":[248],"insulin,":[251],"respectively)":[252],"while":[253],"inhibitors":[255,286],"neutral.":[258],"had":[263,287,322],"more":[264],"gastrointestinal":[265],"side":[266],"effects":[267],"(risk":[268,293,312],"ratio,":[269,294,313],"2.9":[270],"2.0-4.2]":[273],"nausea":[275],"3.2":[277],"2.5-4.4]":[280],"vomiting).":[282],"Dipeptidyl":[283],"increased":[289],"risk":[290],"infection":[292],"1.2":[295],"1.0-1.4]":[298],"nasopharyngitis":[300],"1.5":[302],"1.0-2.2]":[305],"urinary":[307],"tract":[308],"infection)":[309],"headache":[311],"1.4":[314],"1.1-1.7]).":[317],"All":[318],"3":[320],"a":[323,360],"30-week":[324],"shorter":[326],"duration;":[327],"thus,":[328],"long-term":[329],"could":[333],"be":[335],"evaluated.":[336],"CONCLUSIONS:":[337],"Incretin":[338],"offers":[340],"alternative":[342],"option":[343],"currently":[345],"available":[346],"agents":[348],"diabetes,":[355],"modest":[357],"favorable":[361],"weight-change":[362],"profile.":[363],"Careful":[364],"postmarketing":[365],"surveillance":[366],"adverse":[368],"effects,":[369],"especially":[370],"among":[371,395],"inhibitors,":[374],"continued":[376],"longer-term":[379],"studies":[380],"clinical":[383],"practice":[384],"are":[385],"required":[386],"determine":[388],"this":[392],"new":[393],"class":[394],"current":[396],"pharmacotherapies":[397]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":17},{"year":2023,"cited_by_count":22},{"year":2022,"cited_by_count":26},{"year":2021,"cited_by_count":27},{"year":2020,"cited_by_count":38},{"year":2019,"cited_by_count":34},{"year":2018,"cited_by_count":23},{"year":2017,"cited_by_count":36},{"year":2016,"cited_by_count":52},{"year":2015,"cited_by_count":74},{"year":2014,"cited_by_count":67},{"year":2013,"cited_by_count":79},{"year":2012,"cited_by_count":77}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}